Abdulmajeed Alayyaf | Inorganic molecular development | Best Paper Award

Best Paper Award

Abdulmajeed Alayyaf
King Saud University
Abdulmajeed Alayyaf
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 58306966000
Documents 28
Citations 210
h-index 9
Subject Area Inorganic molecular development
Event International Chemistry Scientist Awards
ORCID 0009-0000-3377-4115

The Best Paper Award recognizes the scholarly and scientific contributions of Abdulmajeed Alayyaf in the field of inorganic molecular development and related chemical sciences. The recognition is associated with research productivity, publication quality, citation performance, and scientific engagement within the broader international chemistry research community. The award profile highlights academic contributions documented through indexed publications and citation databases.[1]

Abstract

Abdulmajeed Alayyaf has contributed to the advancement of inorganic molecular development through scientific publications indexed in international academic databases. Research outputs associated with this profile include studies in chemical synthesis, molecular characterization, and applied inorganic systems. Citation metrics and publication records indicate sustained academic participation and measurable research visibility within the field of chemistry.[1][2]

Keywords

Best Paper Award, Abdulmajeed Alayyaf, inorganic molecular development, chemistry research, Scopus author profile, King Saud University, chemical sciences, molecular chemistry, academic recognition, research publications

Introduction

The International Chemistry Scientist Awards recognize researchers demonstrating scientific productivity and academic contributions in chemistry-related disciplines. Abdulmajeed Alayyaf has been identified as a contributor within inorganic molecular development, with research activity documented through indexed scholarly outputs and citation tracking systems.[1]

Research Profile

Abdulmajeed Alayyaf is affiliated with King Saud University in Saudi Arabia and has established a research profile centered on inorganic molecular development and associated chemical systems. Indexed academic metrics indicate a publication record comprising 28 documents with more than 200 citations and an h-index of 9.[1]

  • Institutional affiliation with King Saud University.
  • Research specialization in inorganic molecular development.

Research Contributions

The research contributions associated with Abdulmajeed Alayyaf involve participation in scientific investigations related to molecular systems, inorganic chemistry methodologies, and laboratory-based analytical development. These studies contribute to broader chemical science applications through experimental design and material characterization approaches.[2]

Publications

The publication record associated with the researcher includes scientific articles indexed through Scopus and related academic databases. Publication themes are connected to inorganic chemistry, molecular systems, and chemical development studies.[1]

  1. Research studies involving inorganic molecular systems and chemical analysis methodologies.
  2. Peer-reviewed chemistry publications indexed through international scholarly databases.

Research Impact

Research impact metrics associated with Abdulmajeed Alayyaf indicate measurable scholarly visibility through citations, publication indexing, and academic referencing. Citation activity reflects the integration of published work into broader scientific discussions and ongoing chemistry-related investigations.[1]

Award Suitability

The Best Paper Award evaluation framework emphasizes publication quality, citation relevance, academic contribution, and subject-specific impact. Abdulmajeed Alayyaf’s documented academic profile aligns with these criteria through indexed publication activity, measurable citations, and sustained engagement in inorganic molecular development research.[3]

Conclusion

Abdulmajeed Alayyaf’s academic profile demonstrates recognized participation in inorganic molecular development and chemistry-related research. Indexed publications, citation records, and institutional affiliation collectively indicate scholarly engagement and measurable research contribution. The Best Paper Award recognition framework reflects these academic indicators through evaluation of publication impact, scientific quality, and research dissemination.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Abdulmajeed Alayyaf, Author ID 58306966000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58306966000
  2. ORCID. (n.d.). ORCID profile of Abdulmajeed Alayyaf.
    https://orcid.org/0009-0000-3377-4115
  3. Al‐Jassas, R. M., Islam, M. S., Al‐Majid, A. M., Nafie, M. S., & Haukka, M. Synthesis and SARs study of novel spiro‐oxindoles as potent antiproliferative agents with CDK‐2 inhibitory activities.
    https://pubmed.ncbi.nlm.nih.gov/37253118/
  4. Saidani, A., Boudraa, R., Fendi, K., Benouadah, L., Benabbas, A., & Djermoune, A. Effect of calcination temperature on the photocatalytic activity of precipitated ZnO nanoparticles for the degradation of rhodamine B under different light sources.
    https://www.mdpi.com/2073-4441/17/1/32

Assoc. Prof. Dr. Alicja Nowaczyk | Molecular | Medical Chemistry Award

Assoc. Prof. Dr. Alicja Nowaczyk | Molecular | Medical Chemistry Award

Assoc. Prof. Dr. Alicja Nowaczyk | The Head Of The Department Of Pharmacometrics And Molecular Modeling | Nicolaus Copernicus University |  Poland 

Assoc. Prof. Dr. Alicja Nowaczyk is an accomplished Associate Professor at the Department of Organic Chemistry, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland. She is a leading expert in pharmaceutical and medical sciences, with extensive research in computational chemistry, molecular modeling, neuropharmacology, cardiovascular pharmacology, and predictive modeling of biologically active compounds. Her scientific pursuits focus on molecular interactions related to GABA transporters (GAT), monoamine transporters (MAT), voltage-gated ion channels (VGIC), cytochrome P450 (CYP), receptor tyrosine kinases (RTK), and guanylyl cyclase (GC). Over the years, Dr. Nowaczyk has published 61 scientific documents, which have received 1,094 citations from 998 sources, reflecting her academic influence and international recognition. Her h-index of 18 and i10-index of 39 demonstrate consistent research productivity and citation impact, while since 2020, her performance has further increased with 1,421 citations and an h-index of 20, marking her as a prominent figure in computational pharmacology. She leads the Department of Pharmacometrics and Molecular Modeling, supervising several Ph.D. theses, coordinating collaborative research, and mentoring international scholars. Dr. Nowaczyk’s contributions to science are recognized through numerous awards from the Rector of Nicolaus Copernicus University and the Minister of Health, as well as through her role as a reviewer for over 200 international scientific manuscripts across major publishers like Elsevier, Springer, MDPI, Wiley, and Taylor & Francis. Her ongoing projects continue to integrate AI, machine learning, and in silico modeling into modern drug discovery and safety pharmacology.

Profile : Scopus | Orcid | Google Scholar 

Featured Publications :

  • Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., Jamil, A., & Nowaczyk, A. (2025). PROTAC technology as a new tool for modern pharmacotherapy. Molecules, 30(10), 2123.

  • Kalisz, O., Tobiszewski, M., Nowaczyk, A., & Bocian, S. (2024). Exploring the potential of green chemistry in reversed-phase liquid chromatography: A review of sustainable solvents. TrAC – Trends in Analytical Chemistry, 181, 118007.

  • Ziętal, K., Mirowska-Guzel, D., Nowaczyk, A., & Blecharz-Klin, K. (2024). Cnicus benedictus: Folk medicinal uses, biological activities, and in silico screening of main phytochemical constituents. Planta Medica, 90(13), 976–991.

  • Badura, A., Pałkowski, Ł., Nowaczyk, A., Poćwiartowska-Gołąb, M., & Buciński, A. (2023). Application of artificial neural networks for predicting imidazole derivatives’ antimicrobial activity against Enterococcus faecalis. Farmacja Polska, 79(11), 665–676.

  • Grześk, G., Witczyńska, A., Węglarz, M., Wołowiec, Ł., Nowaczyk, J., & Nowaczyk, A. (2023). Soluble guanylyl cyclase activators: Promising therapeutic option in the pharmacotherapy of heart failure and pulmonary hypertension. Molecules, 28(2), 861.